Blog
How Semaglutide Affects Your Heart Health
Quick Answer:
Semaglutide and heart health are now closely linked. In the SELECT trial, semaglutide lowered the risk of major cardiac events by 20% in adults with obesity and heart disease but without diabetes. In 2024, the FDA approved semaglutide to reduce that risk. The benefit goes beyond weight loss alone.
Key Takeaways
- Semaglutide and heart health are backed by the large SELECT trial.
- SELECT showed a 20% drop in major cardiac events: heart attack, stroke, and cardiovascular death.
- In 2024, the FDA approved semaglutide to reduce heart risk in people with obesity and heart disease.
- The benefit appears to come from more than weight loss, including blood pressure and inflammation.
- Compounded semaglutide is not FDA-approved and is not a brand substitute.
Does semaglutide protect your heart?
The evidence is strong. In the SELECT trial, published in the New England Journal of Medicine, semaglutide lowered the rate of major cardiac events by 20% compared with placebo, 6.5% versus 8.0%. SELECT enrolled 17,604 adults with a BMI over 27 and existing heart disease, but without diabetes.
Based on that trial, in 2024 the FDA approved semaglutide as the first weight-loss medication shown to reduce the risk of heart attack, stroke, and cardiovascular death in this group. So semaglutide and heart health are now linked in the label, not just in theory.
How does semaglutide help your heart?
Weight loss is only part of the story. Researchers found the heart benefit began before large weight changes, which points to added mechanisms. Semaglutide lowers blood pressure, reduces inflammation, improves blood sugar, and eases strain on blood vessels.
SELECT also found fewer new diabetes cases on semaglutide, 3.5% versus 12%, and a linked analysis showed better kidney outcomes. Heart, blood sugar, and kidney health tend to move together.
| Heart-health measure | What SELECT or linked data showed |
| Major cardiac events | 20% lower risk |
| New diabetes onset | 3.5% vs 12% |
| Kidney outcomes | Composite risk lower, HR 0.78 |
| When benefit started | Before major weight loss |
Who benefits most from the heart effect?
SELECT studied people with obesity and established heart disease, and that group saw the clearest benefit. If you take semaglutide for weight loss and have heart risk factors, this data is reassuring, but your provider should weigh your full history first.
What does this mean if you take semaglutide for weight loss?
The takeaway for a woman losing weight on semaglutide is simple. The medication may be doing quiet work for your heart while you focus on the scale. It is not a standalone treatment for existing heart disease, and compounded semaglutide is not FDA-approved. Use it under provider guidance. Read more on GLP-1 benefits beyond weight loss and whether GLP-1s are safe long term.
Frequently asked questions
Does semaglutide help your heart?
Yes, based on the SELECT trial. Semaglutide lowered major cardiac events by 20% in adults with obesity and heart disease but without diabetes, and the FDA approved it for heart-risk reduction in 2024.
What did the SELECT trial show?
SELECT enrolled 17,604 adults and found semaglutide cut the rate of heart attack, stroke, and cardiovascular death to 6.5% versus 8.0% on placebo, a 20% relative reduction.
How does semaglutide protect the heart?
Through more than weight loss. Semaglutide lowers blood pressure, reduces inflammation, improves blood sugar, and eases vascular strain. The benefit began before major weight changes.
Is semaglutide approved for heart disease?
In 2024 the FDA approved semaglutide to reduce major cardiac events in adults with obesity or overweight and established cardiovascular disease, without diabetes.
Does compounded semaglutide have the same heart data?
No. The trials studied the FDA-approved brand. Compounded semaglutide is not FDA-approved and has not been studied the same way.
Can semaglutide lower blood pressure?
Yes, modestly. Lower blood pressure is one of the mechanisms thought to contribute to the heart benefit seen in trials.
Does semaglutide prevent diabetes?
In SELECT, fewer participants developed diabetes on semaglutide, 3.5% versus 12%. That is a metabolic benefit alongside the heart effect.
Who should consider semaglutide for heart protection?
People with obesity and established heart disease saw the clearest benefit in trials. A provider should review your full history before prescribing.
Is semaglutide a replacement for heart medication?
No. Semaglutide is not a standalone heart treatment. Keep taking prescribed heart medications and follow your cardiologist’s plan.
Does tirzepatide have the same heart data?
Tirzepatide has a large cardiovascular trial with results expected later. As of now, semaglutide has the stronger published heart-outcome evidence.
Free AHC Weight Loss Calculators and Tools
Run your own numbers before your visit. These free tools are open to everyone.
• AHC weight loss calculators (all tools)
• GLP-1 weight loss projection calculator
• GLP-1 cost and savings calculator
See if semaglutide fits your plan
A licensed provider can weigh the benefits and your history. Start your free evaluation with Alternate Health Club, where compounded semaglutide is a flat $129 a month with no dose-escalation markups.
Medical disclaimer
This article is for general education and is not medical advice. The assessment offered by Alternate Health Club does not create a doctor-patient relationship. All clinical services are provided by independently contracted, U.S.-licensed clinicians who determine eligibility for compounded GLP-1 or GLP-1+GIP treatment based on your medical history, assessment responses, and any participation in related Weight Loss Plans. Providers retain full discretion to prescribe or decline compounded medications. All compounded products made available through AHC are not FDA-approved and have not been reviewed by the FDA for safety, efficacy, or quality. Results vary by individual and depend on adherence, clinical guidance, and lifestyle factors. AHC does not manufacture medications, and product appearance may differ from images shown on the website. Any brand-name references belong to their respective trademark owners and are used only for educational context.